Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection

[1] Allison JE(2006)Screening tests for colorectal cancer: a menu of options remains relevant Curr. Oncol. Rep. 8 492-498

[2] Lawson M(2010)Contrasting US and European approaches to colorectal cancer screening: which is best? Gut 59 407-414

[3] Hoff G(2008)Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening World J. Gastroenterol. 14 524-531

[4] Dominitz JA(2009)Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer Cancer Res. 69 4691-4699

[5] Wang DR(2009)N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer J Natl Cancer Inst 101 916-927

[6] Tang D(2012)DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT Cancer Prev Res Phila 5 464-472

[7] Glockner SC(2011)Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis Int. J. Clin. Pract. 65 1313-1320

[8] Dhir M(2011)Molecular tests for colorectal cancer screening Clin. Colorectal Cancer 10 8-23

[9] Yi JM(2005)DNA stabilization is critical for maximizing performance of fecal DNA-based colorectal cancer tests Diagn. Mol. Pathol. 14 183-191

[10] McGarvey KE(2010)Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test Aliment. Pharmacol. Ther. 31 432-439

[1] Allison JE(2006)Screening tests for colorectal cancer: a menu of options remains relevant Curr. Oncol. Rep. 8 492-498

[2] Lawson M(2010)Contrasting US and European approaches to colorectal cancer screening: which is best? Gut 59 407-414

[3] Hoff G(2008)Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening World J. Gastroenterol. 14 524-531

[4] Dominitz JA(2009)Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer Cancer Res. 69 4691-4699

[5] Wang DR(2009)N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer J Natl Cancer Inst 101 916-927

[6] Tang D(2012)DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT Cancer Prev Res Phila 5 464-472

[7] Glockner SC(2011)Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis Int. J. Clin. Pract. 65 1313-1320

[8] Dhir M(2011)Molecular tests for colorectal cancer screening Clin. Colorectal Cancer 10 8-23

[9] Yi JM(2005)DNA stabilization is critical for maximizing performance of fecal DNA-based colorectal cancer tests Diagn. Mol. Pathol. 14 183-191

[10] McGarvey KE(2010)Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test Aliment. Pharmacol. Ther. 31 432-439